Connecticut Transparency Law: APRN Payment Reporting Date Pushed Back to…
We recently covered a new Connecticut law that requires pharmaceutical and device companies to report payments made to…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
May 2014
ASCO Not Enforcing Pharmaceutical and Device Speaker Ban in 2014
This weekend opens the largest oncology meeting in the world ASCO 2014 in Chicago, IL. Over 20,000 oncologists from…
FDA Draft Guidance: Best Practices in Developing Proprietary Drug Names
Medication errors account for an estimated 7,000 deaths annually, according to a 1999 Institute of Medicine (IOM)…
French Sunshine Act: Public Database Published
As we've said a lot this year, transparency is a global phenomenon. The Loi Bertrand, or the French Sunshine Act, is similar in…
FDA to Consider Expanding Scientific Exchange
At the 2014 FDLI Annual Conference, senior officials at FDA noted that the agency is not taking lightly industry's concerns…
FDA Relaxing Controls on Imported Products for 13 Pharmaceutical Companies
The Food and Drug Administration (FDA) is loosening the regulatory controls for 13 pharmaceutical companies that will…
HHS-OIG Releases Updated Advisory on Independent Charity Patient Assistance…
Back in 2005, OIG concluded that pharmaceutical manufacturer patient assistance programs (PAPs) that subsidize Part D…
Pakistan Looks to Increase Transparency between Healthcare Providers and…
Pakistan may be the latest country onsidering increasing transparency in interactions between healthcare providers and industry.…
Physician Payments Sunshine Act: Phase 2 Data Submission and Attestation…
On June 1, applicable manufacturers and applicable group purchasing organizations (GPOs) will start Phase 2 of Open…
DC Transparency Law: Companies Won’t Have to Report Payments Made to DC…
The District of Columbia's AccessRX Act of 2004 has required pharmaceutical companies to report their marketing…